Literature DB >> 15271938

Experimental infections of neonatal mice with cysts of Giardia lamblia clone GS/M-83-H7 are associated with an antigenic reset of the parasite.

N von Allmen1, M Bienz, A Hemphill, N Müller.   

Abstract

Transmission of the protozoan parasite Giardia lamblia from one to another host individuum occurs through peroral ingestion of cysts which, following excystation in the small intestine, release two trophozoites each. Many studies have focused on the major surface antigen, VSP (for variant surface protein), which is responsible for the antigenic variability of the parasite. By using trophozoites of G. lamblia clone GS/M-83-H7 (expressing VSP H7) and the neonatal mouse model for experimental infections, we quantitatively assessed the process of antigenic variation of the parasite on the transcriptional level. In the present study, variant-specific regions identified on different GS/M-83-H7 vsp sequences served as targets for quantitative reverse transcription-PCR to monitor alterations in vsp mRNA levels during infection. Respective results demonstrated that antigenic switching of both the duodenal trophozoite and the cecal cyst populations was associated with a massive reduction in vsp H7 mRNA levels but not with a simultaneous increase in transcripts of any of the subvariant vsp genes analyzed. Most importantly, we also explored giardial variant-type formation and vsp mRNA levels after infection of mice with cysts. This infection mode led to an antigenic reset of the parasite in that a VSP H7-negative inoculum "converted" into a population of intestinal trophozoites that essentially consisted of the original VSP H7 type. This antigenic reset appears to be associated with excystation rather than with a selective process which favors expansion of a residual population of VSP H7 types within the antigenically diversified cyst inoculum. Based on these findings, the VSP H7 type has to be regarded as a predominant variant of G. lamblia clone GS/M-83-H7 which (re-)emerges during early-stage infection and may contribute to an optimal establishment of the parasite within the intestine of the experimental murine host.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271938      PMCID: PMC470631          DOI: 10.1128/IAI.72.8.4763-4771.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Characterization of a Giardia lamblia variant-specific surface protein (VSP) gene from isolate GS/M and estimation of the VSP gene repertoire size.

Authors:  T E Nash; M R Mowatt
Journal:  Mol Biochem Parasitol       Date:  1992-04       Impact factor: 1.759

2.  Antigenic variation in Giardia lamblia: infection of congenitally athymic nude and scid mice.

Authors:  B Gottstein; T E Nash
Journal:  Parasite Immunol       Date:  1991-11       Impact factor: 2.280

3.  Cysteine-rich variant surface proteins of Giardia lamblia.

Authors:  A Aggarwal; J W Merritt; T E Nash
Journal:  Mol Biochem Parasitol       Date:  1989-01-01       Impact factor: 1.759

4.  Giardia lamblia: identification and characterization of a variant-specific surface protein gene family.

Authors:  T E Nash; J T Conrad; M R Mowatt
Journal:  J Eukaryot Microbiol       Date:  1995 Sep-Oct       Impact factor: 3.346

5.  Antigenic switching of TSA 417, a trophozoite variable surface protein, following completion of the life cycle of Giardia lamblia.

Authors:  T C Meng; M L Hetsko; F D Gillin
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile.

Authors:  D B Keister
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

7.  Isolate and epitope variability in susceptibility of Giardia lamblia to intestinal proteases.

Authors:  T E Nash; J W Merritt; J T Conrad
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

8.  Antigenic variation in Giardia lamblia: cellular and humoral immune response in a mouse model.

Authors:  B Gottstein; G R Harriman; J T Conrad; T E Nash
Journal:  Parasite Immunol       Date:  1990-11       Impact factor: 2.280

9.  Antigenic variation of Giardia lamblia in vivo.

Authors:  A Aggarwal; T E Nash
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

10.  Giardia lamblia infections in Mongolian gerbils: an animal model.

Authors:  M Belosevic; G M Faubert; J D MacLean; C Law; N A Croll
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

View more
  6 in total

1.  Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model.

Authors:  Gabriela Jenikova; Petr Hruz; Mattias K Andersson; Noa Tejman-Yarden; Patricia C D Ferreira; Yolanda S Andersen; Barbara J Davids; Frances D Gillin; Staffan G Svärd; Roy Curtiss; Lars Eckmann
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

2.  Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.

Authors:  Noa Tejman-Yarden; Maya Millman; Tineke Lauwaet; Barbara J Davids; Frances D Gillin; Linda Dunn; Jacqueline A Upcroft; Yukiko Miyamoto; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

3.  TprK sequence diversity accumulates during infection of rabbits with Treponema pallidum subsp. pallidum Nichols strain.

Authors:  Rebecca E LaFond; Arturo Centurion-Lara; Charmie Godornes; Wesley C Van Voorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

4.  Parasites induced skin allergy: a strategic manipulation of the host immunity.

Authors:  Alketa Hysni Bakiri; Ervin Cerciz Mingomataj
Journal:  J Clin Med Res       Date:  2010-12-11

5.  snoRNA, a novel precursor of microRNA in Giardia lamblia.

Authors:  Ashesh A Saraiya; Ching C Wang
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

6.  Draft genome sequencing of giardia intestinalis assemblage B isolate GS: is human giardiasis caused by two different species?

Authors:  Oscar Franzén; Jon Jerlström-Hultqvist; Elsie Castro; Ellen Sherwood; Johan Ankarklev; David S Reiner; Daniel Palm; Jan O Andersson; Björn Andersson; Staffan G Svärd
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.